Relationships between neurocognitive functioning, mood, and quality of life in patients with temporal lobe glioma

Published on May 1, 2017in Psycho-oncology3.894
· DOI :10.1002/PON.4046
Kyle R. Noll11
Estimated H-index: 11
(University of Texas MD Anderson Cancer Center),
Mariana E. Bradshaw4
Estimated H-index: 4
(University of Texas MD Anderson Cancer Center)
+ 1 AuthorsJeffrey S. Wefel31
Estimated H-index: 31
(University of Texas MD Anderson Cancer Center)
Sources
Abstract
Objective While neurocognitive functioning (NCF) and mood disturbance share a relationship with health-related quality of life (HRQOL), few studies have examined relationships between these constructs in glioma patients prior to treatment. Methods Newly diagnosed patients with glioma in the left (N = 73; 49% glioblastoma) or right (N = 30; 57% glioblastoma) temporal lobe completed neuropsychological testing and self-report measures of HRQOL (Functional Assessment of Cancer Therapy (FACT)-General and Brain module) and mood (Beck Depression Inventory-Second Edition and State-Trait Anxiety Inventory). Results Verbal learning and memory, executive function, and language abilities were associated with various HRQOL scales. Stepwise linear regression showed that verbal learning predicted scores on the general well-being scale and brain module, processing speed predicted social well-being scores, and executive functioning predicted functional well-being scores on the FACT. Upper extremity strength also predicted scores on the functional well-being subscale and brain module. Mood was more strongly associated with HRQOL domains than NCF, with depressive symptoms accounting for a large proportion of variance across most subscales. Conclusions In patients with temporal lobe glioma, depressive symptoms are strongly related to most aspects of HRQOL but not with NCF. NCF, specifically verbal learning and memory, executive functioning, and processing speed, also show direct relationships with numerous aspects of HRQOL. These findings underscore the importance of multimodal assessment of NCF and mood in this population. Copyright © 2015 John Wiley & Sons, Ltd.
Download
📖 Papers frequently viewed together
20004.65Neurosurgery
4 Authors (Oliver Tucha, ..., Klaus W. Lange)
References32
Newest
#1Kyle R. NollH-Index: 11
#2Catherine M. Sullaway (University of Texas MD Anderson Cancer Center)H-Index: 3
Last. Jeffrey S. WefelH-Index: 31
view all 5 authors...
Glioma comprises the vast majority of all malignant primary brain tumors.1 These tumors often disrupt cerebral function through direct mechanisms such as destruction of brain tissue, as well as more indirect means, including compression, displacement, and ischemia.2 As a result, most patients exhibit some impairment of neurocognitive function (NCF), even early in the disease course.3,4 However, when compared with patients with acute lesions related to stroke or trauma, individuals with brain tum...
Source
#1Kyle R. Noll (University of Texas MD Anderson Cancer Center)H-Index: 11
#2Abigail Garbarino (University of Texas MD Anderson Cancer Center)H-Index: 1
Last. Jeffrey S. Wefel (University of Texas MD Anderson Cancer Center)H-Index: 31
view all 5 authors...
OBJECTIVE: Depression and neurocognitive function (NCF), particularly executive functioning (EF), have been associated with overall survival (OS) in patients with glioblastoma (GBM). However, the combined effect of depression and impaired EF has not been reported. METHODS: Patients with GBM (n = 102) completed neuropsychological assessment postoperatively (mean = 23.5 days post surgery) including the Beck Depression Inventory-Second Edition (BDI-II) and the Trail Making Test Part B (TMTB). Media...
Source
#1Cecelia E. Gzell (RNSH: Royal North Shore Hospital)H-Index: 7
#2Helen Wheeler (USYD: University of Sydney)H-Index: 29
Last. Michael Back (USYD: University of Sydney)H-Index: 24
view all 5 authors...
Purpose Radiotherapy (RT) and temozolomide (TMZ) for glioblastoma (GBM) has resulted in longer survival. Uncertainties exist regarding quality of survival. This study aims to determine the rate of patients returning to previous employment (EM) following treatment.
Source
#5Mark R. Gilbert (University of Texas at Austin)H-Index: 86
BACKGROUND Patients with primary brain tumors (PBTs) face uncertainty related to prognosis, symptoms, treatment response, and toxicity. The authors of this report examined the direct/indirect relations among patients' uncertainty, mood states, and symptoms. METHODS In total, 186 patients with PBTs were accrued at various points in the illness trajectory. Data-collection tools included an investigator-completed clinician checklist, a patient-completed demographic data sheet, the Mishel Uncertaint...
Source
#1Philippe SchuchtH-Index: 24
#2Fadi Ghareeb (Riyadh Military Hospital)H-Index: 2
Last. Hugues Duffau (University of Montpellier)H-Index: 107
view all 3 authors...
Object A main concern with regard to surgery for low-grade glioma (LGG, WHO Grade II) is maintenance of the patient's functional integrity. This concern is particularly relevant for gliomas in the central region, where damage can have grave repercussions. The authors evaluated postsurgical outcomes with regard to neurological deficits, seizures, and quality of life. Methods Outcomes were compared for 33 patients with central LGG (central cohort) and a control cohort of 31 patients with frontal L...
Source
#1Marjolein de Groot (VUmc: VU University Medical Center)H-Index: 11
#2Linda DouwH-Index: 31
Last. Jaap C. ReijneveldH-Index: 49
view all 9 authors...
Background. Treatment of high-grade glioma (HGG) patients with anti-epileptic drugs (AEDs) has met with various side effects, such as cognitive deterioration. The cognitive effects of both older and newer AEDs in HGG patients are largely unknown. The aim of this study was to determine the effect of older and newer AEDs on cognitive performance in postoperative HGG patients. Methods. We selected HGG patients from 3 separate cohorts for use of older, newer, or no AEDs, as they represented distinct...
Source
#1Howard Eichenbaum (BU: Boston University)H-Index: 120
#2Magdalena M. Sauvage (RUB: Ruhr University Bochum)H-Index: 21
Last. Paul A. Lipton (BU: Boston University)H-Index: 7
view all 5 authors...
Here we describe a model of medial temporal lobe organization in which parallel “what” and “where” processing streams converge within the hippocampus to represent events in the spatio-temporal context in which they occurred; this circuitry also mediates the retrieval of context from event cues and vice versa, which are prototypes of episodic recall. Evidence from studies in animals are reviewed in support of this model, including experiments that distinguish characteristics of episodic recollect...
Source
#1Elena LampertiH-Index: 17
#2Giuseppe Pantaleo (UniSR: Vita-Salute San Raffaele University)H-Index: 94
Last. Andrea SalmaggiH-Index: 43
view all 8 authors...
Purpose Despite advances in therapies that offer improved survival rates, clinical course of brain tumours leads to a progressive functional deterioration in patients with modifications in their psychological reaction to the disease. Patients with brain tumours are rarely assessed for quality of life and psychological variables, and even fewer studies have assessed patients who have experienced a recurrence of brain tumours. Therefore, the aim of the present study is to investigate the patients ...
Source
#1Derek R. Johnson (Mayo Clinic)H-Index: 21
#2Allison M. Sawyer (University of Texas MD Anderson Cancer Center)H-Index: 2
Last. Jeffrey S. WefelH-Index: 31
view all 5 authors...
Cognitive dysfunction is a common manifestation of primary brain tumors. We evaluated the association between early cognitive dysfunction and prognosis in a cohort of patients with newly diagnosed glioblastoma. Ninety-one patients who completed neuropsychological assessment after tumor resection but before further treatment were identified in the MD Anderson Neuropsychology database. The relationship between performance on cognitive testing and survival was evaluated using not only Cox proportio...
Source
#1John T. Wixted (UCSD: University of California, San Diego)H-Index: 72
#2Larry R. SquireH-Index: 158
Neuroimaging and lesion studies have seemed to converge on the idea that the hippocampus selectively supports recollection. However, these studies usually involve a comparison between strong recollection-based memories and weak familiarity-based memories. Studies that avoid confounding memory strength with recollection and familiarity almost always find that the hippocampus supports both recollection and familiarity. We argue that the functional organization of the medial temporal lobe (MTL) is ...
Source
Cited By25
Newest
#1Lene Haldbo-Classen (Aarhus University Hospital)H-Index: 2
#2Ali Amidi (AU: Aarhus University)H-Index: 13
Last. Morten Høyer (Aarhus University Hospital)H-Index: 45
view all 9 authors...
Abstract null null Aim null This study aimed to explore associations between radiation dose and patient-reported outcomes in patients with a primary non-glioblastoma brain tumour treated with radiation therapy (RT), with a focus on health-related quality-of-life (HRQoL) and self-reported cognitive function. null null null Methods null In this cross-sectional study, 78 patients who had received RT for a non-glioblastoma primary brain tumour, underwent neuropsychological testing and completed ques...
Source
#1Kyle R. Noll (University of Texas MD Anderson Cancer Center)H-Index: 11
#2Amanda L King (NIH: National Institutes of Health)H-Index: 1
Last. Jeffrey S. Wefel (University of Texas MD Anderson Cancer Center)H-Index: 31
view all 6 authors...
Patients with brain tumors experience great symptom burden across various domains of functioning, with associated decreases in health-related quality of life and general well-being. Impaired neurocognitive functioning is among the primary concerns of these patients. Unfortunately, most patients will experience such impairment at some point in the disease. However, impaired neurocognitive functioning, symptom burden, and well-being vary according numerous patient-, tumor-, and treatment-related f...
Source
#1Yaning Wang (Peking Union Medical College Hospital)H-Index: 7
#2Wenlin Chen (Peking Union Medical College Hospital)H-Index: 6
Last. Wenbin Ma (Peking Union Medical College Hospital)H-Index: 20
view all 10 authors...
INTRODUCTION Prognostic situations differ in patients with malignant intracranial tumors. We focused on the quality of life, ability of daily living, and cognitive function of patients in the perisurgery period and investigated the correlation between them and the prognosis of patients. MATERIALS AND METHODS Patients with malignant intracranial tumors admitted to Peking Union Medical College Hospital from May 2018 to August 2020 for surgery were included. The evaluations were performed 6 times i...
Source
#1Mia A Salans (UCSD: University of California, San Diego)H-Index: 3
#2Michelle D. Tibbs (UCSD: University of California, San Diego)H-Index: 5
Last. Tonya M. Pan-Weisz (UCSD: University of California, San Diego)H-Index: 3
view all 12 authors...
ABSTRACT null null Background null We conducted the first prospective longitudinal study examining the independent association between patient-reported hrQoL (physical, social/family, emotional, functional, and brain cancer-specific) and neurocognitive function (NCF), while controlling for mood symptoms in primary brain tumor patients. null null null Methods null Primary brain tumor patients (n=59) receiving brain radiotherapy (RT) underwent hrQOL (Functional Assessment of Cancer Therapy-Brain),...
Source
#1Michael W. Parsons (Harvard University)H-Index: 17
#2Jorg Dietrich (Harvard University)H-Index: 33
Cognitive symptoms occur in almost all patients with brain tumors at varying points in the disease course. Deficits in neurocognitive function may be caused by the tumor itself, treatment (surgery, radiation, or chemotherapy), or other complicating factors (e.g., seizures, fatigue, mood disturbance) and can have a profound effect on functional independence and quality of life. Assessment of neurocognitive function is an important part of comprehensive care of patients with brain tumors. In the n...
Source
#1Christina Weyer-Jamora (UCSF: University of California, San Francisco)H-Index: 2
#2Melissa S Brie (UCSF: University of California, San Francisco)H-Index: 1
Last. Jennie Taylor (UCSF: University of California, San Francisco)H-Index: 20
view all 10 authors...
Outcomes for patients with lower-grade gliomas (LrGGs) continue to improve with advances in molecular characterization and treatment. However, cognitive sequela from the tumor and its treatment leave a significant impact on health-related quality of life for these patients. Several factors affect each patient's cognition, such as tumor location, treatment, medication, and comorbidities. However, impairments of processing speed, attention, concentration, working memory, and executive function are...
Source
Introduction: Thanks to early extensive surgical resection combined with medical oncological therapies, life expectancy dramatically increased in low-grade glioma (LGG), with an overall survival currently over 15 years. Therefore, patients should be able to maintain valuable family and socio-professional activities.Areas covered: For many decades, cognitive and emotional aspects were neglected by surgical and medical neurooncologists. The goal of surgery was to avoid hemiplegia and/or aphasia, w...
Source
#1Christina Weyer-Jamora (UCSF: University of California, San Francisco)H-Index: 2
#2Melissa S Brie (UCSF: University of California, San Francisco)H-Index: 1
Last. Jennie Taylor (UCSF: University of California, San Francisco)H-Index: 20
view all 6 authors...
Intrinsic brain tumors often occur within functional neural networks, leading to neurological impairment and disability of varying degrees. Advances in our understanding of tumor-network integration, human cognition and language processing, and multiparametric imaging, combined with refined intraoperative tumor resection techniques, have enhanced surgical management of intrinsic brain tumors within eloquent areas. However, cognitive symptoms impacting health-related quality of life, particularly...
Source
#1Kyle R. Noll (University of Texas MD Anderson Cancer Center)H-Index: 11
#2Tobias Walbert (HFHS: Henry Ford Health System)H-Index: 21
Last. Jeffrey S. Wefel (University of Texas MD Anderson Cancer Center)H-Index: 31
view all 3 authors...
PURPOSE OF REVIEW This review succinctly summarizes the recent literature regarding etiological contributors to impaired neurocognitive function (NCF) in adult patients with glioma. A brief overview of intervention and prevention strategies is also provided. RECENT FINDINGS A majority of patients with glioma exhibit NCF deficits, most frequently in memory and executive functioning. Impairments are often disabling and associated with reduced quality of life and survival. Cause is multifactorial a...
Source
#1Kyle R. Noll (University of Texas MD Anderson Cancer Center)H-Index: 11
Source
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.